Blend Labs insider plans sale of 17,731 shares

A Rule 144 filing reports that an insider plans to sell up to 17,731 Blend Labs common shares acquired through equity compensation.

Available on EDGAR 09/14/2026 - 04:06 PM EDT Accepted by SEC EDGAR 09/14/2026 - 04:05 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Blend Labs, Inc. (BLND) received a notice that Nima Ghamsari plans to sell common stock under Rule 144. The filing indicates an intention to sell up to 17,731 shares of common stock, originally acquired in connection with a restricted stock lapse and classified as equity compensation.

Key Figures

Shares to be sold: 17,731 shares Approximate market value: $25,267.00 Brokerage firm: Charles Schwab & Co., Inc. +2 more

5 metrics

Shares to be sold 17,731 shares Maximum Blend Labs common shares indicated for sale under Rule 144

Approximate market value $25,267.00 Value associated with the 17,731 Blend Labs common shares listed in the securities information

Brokerage firm Charles Schwab & Co., Inc. Firm holding the Blend Labs common shares described in the filing

Issuing company Blend Labs, Inc. Issuer of the common stock covered by this Form 144

Rule Rule 144 Securities Act rule governing the planned resale of restricted or control securities

Key Terms

Rule 144, Restricted Stock Lapse, Equity Compensation, Form 144

4 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Restricted Stock Lapse financial

"Common | 11/20/2025 | Restricted Stock Lapse | BLEND LABS, INC."

Equity Compensation financial

"17731 | 11/20/2025 | Equity Compensation"

Equity compensation is pay given to employees, executives or contractors in the form of company ownership—such as stock, stock options or restricted shares—rather than just cash. It matters to investors because it can align workers' incentives with shareholders (like paying someone in slices of the same pie they help grow), but it also increases the number of shares outstanding and company expenses, affecting ownership percentages and earnings per share.

Form 144 regulatory

"144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing disclose for Blend Labs, Inc. (BLND)?

It discloses that Nima Ghamsari has filed a notice of intent under Rule 144 to sell up to 17,731 shares of Blend Labs, Inc. common stock that were acquired as equity compensation through a restricted stock lapse.

How many Blend Labs (BLND) shares are covered by this Rule 144 notice?

The notice covers up to 17,731 shares of common stock. This is the quantity listed in the section describing the securities to be sold under Rule 144.

What type of Blend Labs (BLND) securities is the insider planning to sell?

The planned sale involves common stock of Blend Labs, Inc. held in a brokerage account at Charles Schwab & Co., Inc., as described in the securities information section.

How were the Blend Labs (BLND) shares to be sold originally acquired?

The filing states that the shares were acquired through a restricted stock lapse and are categorized as equity compensation from Blend Labs, Inc.

Does the Form 144 sale provide proceeds to Blend Labs (BLND)?

No. A Form 144 filing describes a planned resale by a security holder. It involves sales for the account of the filing person, not a new issuance by Blend Labs, Inc.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001870974
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Blend Labs, Inc.
SEC File Number	001-40599
Address of Issuer	7250 REDWOOD BLVD., SUITE 300 NOVATO CALIFORNIA 94945
Phone	(650) 550-4810
Name of Person for Whose Account the Securities are To Be Sold	Ghamsari Nima
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	17731	25267.00	233256934	09/14/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/20/2025	Restricted Stock Lapse	BLEND LABS, INC.			17731	11/20/2025	Equity Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks
Date of Notice	09/14/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/15/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	NIMA GHAMSARI
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)